Log In
BCIQ
Print this Print this
 

BP-C2

  Manage Alerts
Collapse Summary General Information
Company Meabco A/S
DescriptionCombination of BP-Cx-1, a globular polydentant ligand, and molybdenum salts
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationPoisoning
Indication DetailsPrevention and treatment of side effects from radiation exposure
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today